Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-001308

General Counsel acquired 28,000 shares (option exercise)

  • General Counsel acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

O'Brien Patrick · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-31 Exercise or conversion : show line 1 in the form +28,000 $6.15 $172,200 321,375 D
2022-01-01 Grant or award : show line 2 in the form +60,000 381,375 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-12-31 Exercise or conversion : show line 3 in the form Stock Option (right to buy Common Stock) −28,000 32,000 D
Loading xslF345X03/doc4.xml…